scholarly journals Valvular heart diseases (7). Result of cardiac operation for valvular heart disease with cardiac cachexia.

1990 ◽  
Vol 19 (4) ◽  
pp. 754-755
Author(s):  
T. Sakamoto
Keyword(s):  
Heart Disease ◽  
Valvular Heart Disease ◽  
Heart Diseases ◽  
Cardiac Cachexia ◽  
Cardiac Operation ◽  
Valvular Heart Diseases

Abstract 163: High Burden of Valvulopathy in Heart Failure: A Moving Target

2016 ◽  
Vol 9 (suppl_2) ◽  
Author(s):  
Enoch Agunanne ◽  
Aamer Abbas ◽  
Debabrata Mukherjee
Keyword(s):  
United States ◽  
Heart Failure ◽  
Heart Disease ◽  
Valvular Heart Disease ◽  
Heart Diseases ◽  
Medical Center ◽  
Care Facility ◽  
The United States ◽  
Study Objective ◽  
Valvular Heart Diseases

Background: The lifetime risk of developing Heart Failure (HF) is 20% for Americans ≥40 years of age. In the United States, greater than 650,000 new HF cases are diagnosed annually. About 5.1 million persons in the United States have clinically manifest HF. Additionally, HF has high absolute mortality rates of approximately 50% within 5 years of diagnosis. HF carries substantial health and economic burden. It is the primary diagnosis in >1 million hospitalizations annually. Patients hospitalized for HF are at high risk for all-cause re hospitalization. The total cost of HF care in the United States exceeds $30 billion annually. Objective: The study objective was to investigate the prevalence of valvular heart disease among patients hospitalized for HF in a largely Hispanic population. Methods: This is a retrospective study with aims inclusive of: analyzing the hospitalization and 4 months, 6 months, 2 year- re-hospitalization rates of HF in University Medical Center between Oct 2010 and Oct 2013; evaluating the association between valvular heart disease and hospitalizations for HF. Inclusion criteria were: admission/re hospitalizations with HF (with reduced, preserved and borderline EF). Echocardiographic determination of at least moderate valvular disease was utilized in this study as significant. Exclusion criteria were: patients lost to follow-up, death in hospital, transfer to another acute care facility, and discharge against medical advice. Demographics were also collected. Results: Hospitalizations involving 195 patients (120 men and 75 women) were randomly analyzed. The racial spread showed 77.4% (151 of 195) Hispanics and 22.6% (44 of 195) non-Hispanics. Out of the 195 index hospitalizations, the 4 month, 6 months and 2 years rehospitalization visits were 17.4% (34 of 195), 22.5% (44 of 195) and 38.5% (75 of 195) respectively. The prevalence of significant valvular heart disease was 45.9% (90 of 195), while the prevalence of no valvular heart disease was 54.1% (105 of 195) (p < 0.05). Conclusion: Multiple, prior studies have shown that valvular heart diseases have a comparatively low association with clinical Heart Failure. This study raises a valid point that in some population groups (the Hispanic), the burden of valvular heart disease may be greater than has been published in other groups. This calls for more studies, and has lots of potential implications in Heart Failure management.

scholarly journals Exercise Right Heart Catheterisation in Cardiovascular Diseases: A Guide to Interpretation and Considerations in the Management of Valvular Heart Disease

2021 ◽  
Vol 16 ◽  
Author(s):  
Felipe H Valle ◽  
Basma Mohammed ◽  
Stephen P Wright ◽  
Robert Bentley ◽  
Neil P Fam ◽  
...  
Keyword(s):  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Valvular Heart Disease ◽  
Heart Diseases ◽  
Pulmonary Resistance ◽  
Right Heart ◽  
Heart Catheterisation ◽  
Right Heart Catheterisation ◽  
Valvular Heart Diseases ◽  
Transcatheter Interventions

The use of exercise right heart catheterisation for the assessment of cardiovascular diseases has regained attention recently. Understanding physiologic haemodynamic exercise responses is key for the identification of abnormal haemodynamic patterns. Exercise total pulmonary resistance >3 Wood units identifies a deranged haemodynamic response and when total pulmonary resistance exceeds 3 Wood units, an exercise pulmonary artery wedge pressures/cardiac output slope >2 mmHg/l/min indicates the presence of underlying exercise-induced pulmonary hypertension related to left heart disease. In the evolving field of transcatheter interventions for valvular heart disease, exercise right heart catheterisation may objectively unmask symptoms and underlying haemodynamic abnormalities. Further studies are needed on the use of the procedure to inform the selection of patients who might receive the most benefit from transcatheter interventions for valvular heart diseases.

scholarly journals Critical study of valvular heart diseases W. S. R. to Ayurvedokta Shatkriyakala

2019 ◽  
Vol 7 (06) ◽  
Author(s):  
Subhash Waghe
Keyword(s):  
Heart Disease ◽  
Therapeutic Intervention ◽  
Valvular Heart Disease ◽  
Heart Valves ◽  
Heart Diseases ◽  
Point Of View ◽  
Critical Study ◽  
Throat Infection ◽  
Valvular Heart Diseases ◽  
Principles Of Treatment

Valvular heart diseases leads to definite death by various complications if not treated early. Although it may start as the simple throat infection but eventually it may affect the heart valves if not treated early. Shatkriya Kala is a unique pathological concept in Ayurveda developed with aim of treating the diseases at various stages of pathogenesis. Ancient Ayurvediac acharyas had stated 6 such stages of therapeutic intervention with reference to six stages of pathogenesis namely sanchaya, prakopa, prasara, sthansanshraya, vyakti and bheda.. If disease is treated in early stages, it does not lead to complications. There are vishahra a,d aamhar drugs in Ayurveda which could be potentially used to treat valvular affections. Hence, it is essential to apply the Ayurvedic concept of pathogenesis like ‘Shat Kriyakala’  to valvular heart disease so as to study it from Ayurvedic pathological point of view and to evolve a strategy to deal with it based on the Ayurvedokta principles of treatment particularly in terms of shatkriyakalas. The study of valvular heart disease with reference to Shat Kriyakala, showed that the pathogenesis of valvular heart disease can very well be arranged in Ayurvedokta  six stages of Shat Kriyakala and treatment could be framed as per different stages. With the help of modern investigations, these six stages could be diagnostically confirmed.

scholarly journals Structural Heart Diseases during Pregnancy: Part 1—Valvular Heart Diseases

2018 ◽  
Vol 03 (02/03) ◽  
pp. 108-114
Author(s):  
Amar Patnaik
Keyword(s):  
Heart Disease ◽  
Pregnant Woman ◽  
Pregnant Women ◽  
Valvular Heart Disease ◽  
Heart Diseases ◽  
Medical Science ◽  
Morbidity And Mortality ◽  
Team Approach ◽  
Echocardiographic Evaluation ◽  
Valvular Heart Diseases

AbstractIt is estimated that about 3% pregnancies can have cardiac disease. There is wide variation in the spectrum of heart diseases. Pregnant women in India and other developing countries continue to show high prevalence of rheumatic heart disease (RHD). Pre-conception counseling based on a good echocardiographic evaluation is the most cost-effective method to prevent morbidity and mortality due to valvular heart disease. With advances in medical science, many with valvular heart disease are living to adulthood and undergoing successful pregnancy. Symptoms of a pregnant woman with a valvular disease depend on the altered hemodynamics of the specific valvular lesion in combination with the physiologic changes inherent to the pregnancy itself. A good echocardiographic evaluation of all pregnant women on their first visit to an obstetrician’s office is an effective strategy to prevent morbidity and mortality from valvular heart diseases. In general, the regurgitant lesions are well tolerated during pregnancy and labor. Asymptomatic but significant valve lesions can be decompensated by many factors. Severely stenosed mitral and, sometimes, aortic valve may have to be balloon-dilated by trained experts in midterm taking due care to avoid excess radiation. Valve surgery is rarely performed in absence of any other safer option. A multidisciplinary team approach is required to manage a pregnant woman with significant cardiac lesion with high-risk features and patients having mechanical valves that require continuous anticoagulation.

SOME INNOVATIVE TECHNOLOGIES FOR THE CORRECTION OF VALVULAR HEART DISEASES. REVIEW

2021 ◽  
pp. 22-26
Author(s):  
Inkar Sagatov ◽  
◽  
Askhat Kudaibergen ◽  
Bakhytzhan Momynov
Keyword(s):  
Heart Disease ◽  
Aortic Valve ◽  
Mitral Regurgitation ◽  
Aortic Valve Replacement ◽  
Minimally Invasive ◽  
Valve Replacement ◽  
Valvular Heart Disease ◽  
Heart Diseases ◽  
Reverse Remodeling ◽  
Valvular Heart Diseases

Valve defects or congenital/acquired heart defects are damage to the valve and/or subvalvular structures, which leads to impaired hemodynamics and the development of heart failure. Asymptomatic valvular heart disease is present in 2.5% of the population; with age, this figure rises to 13%. In the absence of permanent treatment, lesions of the heart valves significantly reduce the quality and duration of life. The European Society of Cardiology (ESC) and the American Heart Association (AHA) regularly review the effectiveness of new surgical treatments and reflect their findings in international guidelines. Today, minimally invasive surgery is the most effective and safe way to treat patients with valvular heart disease. The article presents two new methods for the treatment of valvular heart disease. Transapical mitral valve repair on a beating heart with neochord implantation (TOP-MINI) is a new MVP option that has been approved for patients with severe mitral regurgitation due to prolapse of the leaflet (s) or chord (grades 2-4). The new procedure with the NeoChord DS1000 device results in a significant reduction in mitral regurgitation and in reverse remodeling of the left ventricle and left atrium after 6 months of follow-up. Also reviewed is Minimally Invasive Aortic Valve Replacement (MAVR), which has been shown to be beneficial in improving patient satisfaction by minimizing pain and earlier recovery. Sutureless valves are preferred over traditional aortic valve replacement (AVR) due to the reduced operation time and the need for blood transfusion. The Perceval valve (Sorin, Sallugia, Italy) is a self-expanding bovine pericardial prosthesis placed in a nitinol stent designed to facilitate aortic valve implantation. A systematic review and meta-analysis demonstrated that the early clinical and hemodynamic characteristics of the Perceval valve are satisfactory and comparable to those of conventional AVRs. This literature review was carried out in accordance with the PRISM statement. The databases searched in this review included Pubmed, Web of Science, Scopus and Cochrane databases for systematic reviews

scholarly journals Management of patients with acquired valvular heart disease in noncardiac surgery

2021 ◽  
Vol 26 (8) ◽  
pp. 4580
Author(s):  
O. B. Irtyuga ◽  
E. G. Malev ◽  
M. L. Gordeev
Keyword(s):  
Heart Disease ◽  
General Population ◽  
Valvular Heart Disease ◽  
Heart Diseases ◽  
Age Groups ◽  
Noncardiac Surgery ◽  
Russian Society ◽  
Basic Principles ◽  
Valvular Heart Diseases ◽  
Detailed Presentation

Valvular heart disease is widespread among general population, mainly in older age groups, who often require noncardiac surgery. As the population ages, the significance of this problem will only increase. The basic principles of perioperative managing such patients by a multidisciplinary team, necessarily including a cardiologist, are systematized and set out in international clinical guidelines, which are regularly updated. Currently, the Russian Society of Cardiology guidelines on management of valvular heart diseases are being prepared for publication. However, specifics of assessment and management of patients when planning noncardiac surgery require more detailed presentation for a cardiology practitioner.

Sign in / Sign up

Export Citation Format

Share Document